Painful diabetic polyneuropathy - diagnostics and treatment possibilities

被引:0
作者
Rokicka, Dominika [1 ]
Wrobel, Marta [1 ]
Szymborska-Kajanek, Aleksandra [1 ]
Bozek, Anna [1 ]
Strojek, Krzysztof [1 ]
机构
[1] Slaski Uniwersytet Med, Katedra & Klin Chorob Wewnetrznych Diabetol & Nef, Ul 3 Maja 13-15, PL-41800 Zabrze, Poland
来源
CLINICAL DIABETOLOGY | 2012年 / 1卷 / 01期
关键词
diabetes mellitus; painful diabetic polyneuropathy; diagnostics; treatment;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Painful diabetic polyneuropathy is a serious therapeutic problem of contemporary diabetology. Neuropathic pain associated with complication significantly decreases quality of patients' life. The goal is to achieve and maintain accurate glicemic control in the treatment of diabetes since it has been proved that hyperglycemia is the main cause of diabetic neuropathy. The achievement of accurate glycemic control leads to pain reduction. In the majority of cases the use of analgesics and coanalgesics is essential. There are also drugs that are suggested to act on the "cause". The treatment of polyneuropathy is unfortunately not always effective. The aim of this article is to review diagnostic criteria for diabetic neuropathy and current therapeutic possibilities.
引用
收藏
页码:25 / 32
页数:8
相关论文
共 24 条
  • [2] Vitamin B for treating peripheral neuropathy
    Ang, Cynthia D.
    Alviar, Maria Jenelyn M.
    Dans, Antonio L.
    Bautista-Velez, Gwyneth Giselle P.
    Villaruz-Sulit, Maria Vanessa C.
    Tan, Jennifer J.
    Co, Homer U.
    Bautista, Maria Rhida M.
    Roxas, Artemio A.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (03):
  • [3] [Anonymous], 1988, DIABETES, V37, P1000
  • [4] [Anonymous], 2011, DIABET PRAKT SA, V12
  • [5] Diabetic neuropathies - A statement by the American Diabetes Association
    Boulton, AJM
    Vinik, AI
    Arezzo, JC
    Bril, V
    Feldman, EL
    Freeman, R
    Malik, RA
    Maser, RE
    Sosenko, JM
    Ziegler, D
    [J]. DIABETES CARE, 2005, 28 (04) : 956 - 962
  • [6] Diabetic somatic neuropathies
    Boulton, AJM
    Malik, RA
    Arezzo, JC
    Sosenko, JM
    [J]. DIABETES CARE, 2004, 27 (06) : 1458 - 1486
  • [7] Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens
    Freynhagen, R
    Strojek, K
    Griesing, T
    Whalen, E
    Balkenohl, M
    [J]. PAIN, 2005, 115 (03) : 254 - 263
  • [8] Harold E. Lebovitz, 2009, THERAPY DIABETES MEL
  • [9] Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy - A 52-week multicenter placebo-controlled double-blind parallel group study
    Hotta, N
    Toyota, T
    Matsuoka, K
    Shigeta, Y
    Kikkawa, R
    Kaneko, T
    Takahashi, A
    Sugimura, K
    Koike, Y
    Ishii, J
    Sakamoto, N
    [J]. DIABETES CARE, 2001, 24 (10) : 1776 - 1782
  • [10] Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: Randomised doubleblind controlled trial
    Malik, RA
    Williamson, S
    Abbott, C
    Carrington, AL
    Iqbal, J
    Schady, W
    Boulton, AJM
    [J]. LANCET, 1998, 352 (9145) : 1978 - 1981